Wogonin Inhibits Colorectal Cancer Proliferation and Epithelial Mesenchymal Transformation by Suppressing

Yujing Liu1,2, Lu Lu1,2, Peiqiu Cheng1

  • 1Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai 200032, P. R. China.

Insights

Wogonin, a compound from traditional Chinese medicine, effectively inhibits colorectal cancer growth and spread by targeting the AKT signaling pathway. This discovery offers a promising new therapeutic strategy for colorectal cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products

Background:

  • Colorectal cancer (CRC) is a major global health concern and the third leading cause of cancer mortality.
  • Existing therapies for CRC require improvement, necessitating the identification of novel therapeutic agents.
  • Wogonin, a flavonoid derived from *Scutellaria baicalensis*, exhibits potential antitumor properties.

Purpose of the Study:

  • To investigate the inhibitory effects of wogonin on colorectal cancer proliferation, invasion, and metastasis.
  • To elucidate the underlying molecular mechanism of wogonin's antitumor activity in colorectal cancer.

Main Methods:

  • Utilized a phosphorylated protein microarray to analyze signaling pathway phosphorylation in colorectal cancer cells.
  • Conducted *in vitro* and *in vivo* experiments to validate wogonin's efficacy and mechanism of action.
  • Assessed the impact of wogonin on colorectal cancer cell proliferation, invasion, and metastasis.

Main Results:

  • Wogonin significantly suppressed colorectal cancer cell proliferation, invasion, and metastasis.
  • Wogonin intervention markedly reduced the phosphorylation of the AKT protein in colorectal cancer cells.
  • Confirmed that wogonin exerts its antitumor effects by inhibiting AKT pathway phosphorylation.

Conclusions:

  • Wogonin demonstrates significant antitumor activity against colorectal cancer.
  • The mechanism involves the inhibition of AKT protein phosphorylation.
  • Wogonin represents a potential new pharmacological treatment for colorectal cancer by targeting the AKT pathway.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K